Arrowhead Pharmaceuticals
Price & Volume
Stats
See more52W Range | $10.92-$76.76 |
Market Cap | $8.9B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $1B |
Revenue Growth (YoY) | 10,461.3% |
Gross Profit (12 Mos) | $1B |
Diluted EPS | $1.60 |
News
See moreYahoo Finance • last month
Arrowhead (ARWR) FQ1 2026 Revenue Hits $264M as REDEMPLO Approval Marks Commercial Shift
Yahoo Finance • 2 months ago
Arrowhead price target lowered to $78 from $81 at Morgan Stanley
Yahoo Finance • 2 months ago
Arrowhead outlines pivotal 2026 milestones with REDEMPLO launch, $1.33B capital boost, and robust cardiometabolic pipeline
Yahoo Finance • 2 months ago
Arrowhead Pharmaceuticals Inc (ARWR) Q1 2026 Earnings Call Highlights: Strong Financial ...
About
CEO | Dr. Christopher R. Anzalone Ph.D. |
Address | 177 East Colorado Boulevard, Pasadena, CA, United States, 91105 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 711 |
